API | ada-transduced cd34+ cells

ada-transduced cd34+ cells Report issue

Cell therapy Experimental

AACT

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
- Adenosine deaminase (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

ada transduced cells | adenosine deaminase gene transduced hsc | adenosine deaminase gene transduced pbl | adenosine deaminase transduced hematopoietic progenitors | autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ada) cdna sequence from human haematopoietic stem/progenitor (cd34+) cells | autologous efs-ada lv cd34+ cells

Organizations (12)

Research & Development (12)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (5)

Approved Indications (1)

Severe Combined Immunodeficiency

Experimental Indications - Clinical Trial Phases 1-4 (5)

Adenosine Deaminase (Phase 1/Phase 2)

Immune System Diseases (Phase 4)

Immunologic Deficiency Syndromes (Phase 2)

Primary Immunodeficiency Diseases (Phase 1/Phase 2)

Severe Combined Immunodeficiency (Phase 1/Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial Organizations: 12

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue